Market Research Logo

Global Deep Brain Stimulation Market 2016-2020

About Deep Brain Stimulation

A neurostimulation system, also known as a neurostimulator, provides therapeutic activation or modulation in the nervous system at targeted anatomical sites. Deep brain stimulation (DBS) system, a type of neurostimulator, generates electrical stimulation to the targeted areas of the brain and regulates the electrical signals that are generated by the diseased brain cells and neurons.

Technavio’s analysts forecast the global DBS market to grow at a CAGR of 10.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global DBS market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of DBS systems.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Deep Brain Stimulation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Boston Scientific Corp.
  • Medtronic plc
  • St. Jude Medical Inc.
Other prominent vendors
  • Adaptive Neuromodulation
  • Aleva Neurotherapeutics
  • Beijing Pins Medical
  • NeuroPace
  • NeuroSigma
Market driver
  • Increased number of market approvals
  • For a full, detailed list, view our report
Market challenge
  • High cost of DBS therapy
  • For a full, detailed list, view our report
Market trend
  • Hybrid neuroprosthetic devices
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Deep Brain Stimulation Market 2016-2020

Technavio recognizes the following companies as the key players in the Global Deep Brain Stimulation Market: Boston Scientific Corp., Medtronic plc, and St. Jude Medical Inc.

Other Prominent Vendors in the market are: Adaptive Neuromodulation, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, and NeuroSigma.

Commenting on the report, an analyst from Technavio’s team said: “To improve the recovery of motor functions, manufacturers are focusing on combining neuroprosthetic technologies with pharmacological and electrical neuromodulation therapies for the brain, brainstem, and spinal cord. This device is known as hybrid neuroprosthetic devices. In this device, the pharmacological components used include a catheter implanted in the brain tissue and a subcutaneously placed drug reservoir, which can be periodically refilled. A micro-computer is fixed closer to these components, which analyzes the electrophysical data and controls the reservoir. This combination of two technologies can result in much efficient and effective treatment of diseases.”

According to the report, most DBS systems have received CE mark in Europe and then received approval in the US. Frequent approvals by regulatory services boost the market growth. The rise in the number of products seeking approval may help the market grow at a rapid pace during the forecast period.

Further, the report states that high cost of DBS therapy hinders the market growth.

Companies Mentioned

Boston Scientific Corp., Medtronic plc, St. Jude Medical Inc, Adaptive Neuromodulation, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, NeuroSigma.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Approved indications for DBS therapy
      • Table Neurological conditions and their symptoms treated by DBS therapy
    • History of DBS
      • Table History of DBS
  • 13Potential applications of DBS
    • Table Conditions under investigation for DBS therapy
  • Cost of DBS system components and implantation
    • Table Cost of DBS implantation and treatment
    • Table Cost difference between DBS and pharmacological and follow-up cost 2015
    • Table Cost breakdown of DBS components 2015
    • Table Cost breakdown of pharmacological and follow-up cost in DBS 2015
    • Table Adverse event cost (due to surgical error) of DBS implantation 2015
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global DBS market by revenue 2015-2020 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by application
    • Table Global DBS market segmentation by application 2015
    • PD
    • Dystonia
    • OCD
    • Epilepsy
      • Table Global DBS market by application 2015
      • Table Global DBS market by geography 2015
  • Geographical segmentation
    • Table Global DBS market by geography 2020
    • DBS market in Americas
      • Table Conditions treated by DBS in the US
      • Table Economic burden of diseases in the US
      • Table DBS market in Americas 2015-2020 ($ millions)
    • DBS market in EMEA
      • Table Prevalence and financial burden of neurodegenerative diseases in Europe 2010
      • Table DBS market in EMEA 2015-2020 ($ millions)
    • DBS market in APAC
      • Table DBS market in APAC 2015-2020 ($ millions)
      • Table Global DBS market by geography 2015-2020
      • Table Global DBS market by geography 2015-2020 ($ millions)
  • Market drivers
    • Increase in prevalence of neurological disorders
    • Availability of funds and grants for R&D
      • Table Research funding for DBS
    • Increased number of market approvals
      • Table Regulatory approvals for DBS System
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of DBS therapy
    • Complications related to DBS
    • High maintenance and low battery lifetime
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Hybrid neuroprosthetic devices
    • Next-generation therapies for nervous system disorders
    • Emergence of clinician programmer
  • Vendor landscape
    • Competitive scenario
    • Market share analysis
  • Key vendor analysis
    • Boston Scientific
      • Table Boston Scientific: Product portfolio
      • Table Boston Scientific: Neuromodulation segment by revenue 2012-2014 ($ millions)
      • Table Boston Scientific: Key takeaways
    • Medtronic
      • Table Medtronic: Product portfolio
      • Table Medtronic: Neuromodulation segment by revenue 2013-2015 ($ billions)
      • Table Medtronic: Key takeaways
    • St. Jude Medical
      • Table St. Jude Medical: Product portfolio
      • Table St. Jude Medical: Neuromodulation segment by revenue 2012-2014 ($ millions)
      • Table St. Jude Medical: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report